Skip to Content

Anthem Inc ANTM

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Anthem Beats Second-Quarter Estimates and Raises 2021 Guidance; Shares Fairly Valued

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

Narrow-moat Anthem reported second-quarter operating results that beat consensus, and the firm raised its 2021 guidance for the second time this year. At first glance, those trends do not look significant enough to offset a potential increase in the U.S. corporate tax rate, which we plan to start modeling in 2022 and beyond. Therefore, we may trim our fair value estimate slightly, but any change appears likely to be limited to the low single digits on a percentage basis. 

In the quarter, Anthem turned in $7.03 of adjusted EPS, or well above FactSet consensus of $6.34 on lower-than-expected medical utilization. While lower than management expected, medical utilization appeared slightly higher than normal, pre-COVID-19 levels, which represents a turning point since the pandemic began. Also, these results reflected medical membership increasing 4% year over year on the strength of Anthem's government programs (17% growth primarily in Medicaid and Medicare Advantage) offset by weakness in commercial membership (1% decline). In total after the acquisition of MMM (a leading provider of Medicare Advantage and Medicaid plans in Puerto Rico), Anthem's medical membership stood at 44.3 million members at the end of June, overtaking Unitedhealth (44.1 million) as the largest health insurer on a U.S. medical membership basis this quarter. 

Read Full Analysis

Company Profile

Business Description

Anthem is one of the largest private health insurance organizations nationwide, providing medical benefits to roughly 43 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012, Anthem's reach expands beyond those states through government-sponsored programs such as Medicaid, too.

Contact
220 Virginia Avenue
Indianapolis, IN, 46204
T +1 800 331-1476
Sector Healthcare
Industry Healthcare Plans
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2020
Stock Type Aggressive Growth
Employees 83,400

Related

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.